PERSEVERE生物标志物预测儿童脓毒性休克严重急性肾损伤及肾脏恢复
该研究为前瞻性观察性研究的二次分析,纳入379例儿童脓毒性休克患者,测量PERSEVERE生物标志物并计算PERSEVERE-II基线死亡风险。65例(17%)在第3天发生严重脓毒症相关急性肾损伤。校正年龄和病情严重程度后,PERSEVERE-II死亡概率升高与第3天严重脓毒症相关急性肾损伤风险增加独立相关(OR 1.4;95%CI 1.2-1.7;P<0.001),与需要肾脏替代治疗也呈类似关联。PERSEVERE-II死亡概率较低与早期急性肾损伤患者肾脏恢复几率增加独立相关。新模型结合PERSEVERE生物标志物和第1天急性肾损伤状态,预测第3天严重脓毒症相关急性肾损伤的AUC为0.95(95%CI 0.92-0.98)。
要点
- 379例儿童脓毒性休克中65例(17%)在第3天发生严重脓毒症相关急性肾损伤。
- PERSEVERE-II死亡概率升高与第3天严重脓毒症相关急性肾损伤风险增加独立相关(OR 1.4;95%CI 1.2-1.7;P<0.001)。
- PERSEVERE-II死亡概率升高与需要肾脏替代治疗也呈类似关联。
- PERSEVERE-II死亡概率较低与早期急性肾损伤患者肾脏恢复几率增加独立相关。
- 新模型结合PERSEVERE生物标志物和第1天急性肾损伤状态预测第3天严重脓毒症相关急性肾损伤的AUC为0.95(95%CI 0.92-0.98)。
适用人群与场景
- 儿童脓毒性休克患者,来自前瞻性观察性研究的二次分析,共379例。
研究设计与关键结果
- 研究类型:前瞻性观察性研究的二次分析;样本量379例;人群为儿童脓毒性休克患者;测量PERSEVERE生物标志物并计算PERSEVERE-II基线死亡风险。
- 主要结果:65例(17%)发生第3天严重脓毒症相关急性肾损伤;严重脓毒症相关急性肾损伤比例随PERSEVERE-II风险类别升高而直接增加。
- 校正年龄和病情严重程度后,PERSEVERE-II死亡概率升高与第3天严重脓毒症相关急性肾损伤风险增加独立相关(OR 1.4;95%CI 1.2-1.7;P<0.001)。
- PERSEVERE-II死亡概率升高与需要肾脏替代治疗也呈类似关联。
- PERSEVERE-II死亡概率较低与早期急性肾损伤患者肾脏恢复几率增加独立相关。
- 新模型结合PERSEVERE生物标志物和第1天急性肾损伤状态预测第3天严重脓毒症相关急性肾损伤的AUC为0.95(95%CI 0.92-0.98)。
证据类型、等级与局限
- 证据类型:前瞻性观察性研究的二次分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在儿童脓毒性休克中,PERSEVERE生物标志物可预测第3天严重脓毒症相关急性肾损伤,并识别早期急性肾损伤后可能恢复的患者。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Rationale: Acute kidney injury (AKI), a common complication of sepsis, is associated with substantial morbidity and mortality and lacks definitive disease-modifying therapy. Early, reliable identification of at-risk patients is important for targeted implementation of renal protective measures. The updated Pediatric Sepsis Biomarker Risk Model (PERSEVERE-II) is a validated, multibiomarker prognostic enrichment strategy to estimate baseline mortality risk in pediatric septic shock.Objectives: To assess the association between PERSEVERE-II mortality probability and the development of severe, sepsis-associated AKI on Day 3 (D3 SA-AKI) in pediatric septic shock.Methods: We performed secondary analysis of a prospective observational study of children with septic shock in whom the PERSEVERE biomarkers were measured to assign a PERSEVERE-II baseline mortality risk.Measurements and Main Results: Among 379 patients, 65 (17%) developed severe D3 SA-AKI. The proportion of patients developing severe D3 SA-AKI increased directly with increasing PERSEVERE-II risk category, and increasing PERSEVERE-II mortality probability was independently associated with increased odds of severe D3 SA-AKI after adjustment for age and illness severity (odds ratio, 1.4; 95% confidence interval, 1.2-1.7; P < 0.001). Similar associations were found between increasing PERSEVERE-II mortality probability and the need for renal replacement therapy. Lower PERSEVERE-II mortality probability was independently associated with increased odds of renal recovery among patients with early AKI. A newly derived model incorporating the PERSEVERE biomarkers and Day 1 AKI status predicted severe D3 SA-AKI with an area under the received operating characteristic curve of 0.95 (95% confidence interval, 0.92-0.98).Conclusions: Among children with septic shock, the PERSEVERE biomarkers predict severe D3 SA-AKI and identify patients with early AKI who are likely to recover.
参考来源
- Stanski NL, Stenson EK, Cvijanovich NZ, et al. PERSEVERE Biomarkers Predict Severe Acute Kidney Injury and Renal Recovery in Pediatric Septic Shock. Am J Respir Crit Care Med. 2020. PMID: 31916857. doi:10.1164/rccm.201911-2187OC
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。